Medical device company Globus Medical (NYSE:GMED) in Q1 CY2025, with sales falling 1.4% year on year to $598.1 million. On ...

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company ...

Globus Medical, Inc. GMED is well-poised for growth in the coming quarters, backed by the recent NuVasive merger, which brings a comprehensive offering of musculoskeletal procedural solutions and ...

Looking back on medical devices & supplies - specialty stocks’ Q1 earnings, we examine this quarter’s best and worst ...

M edical device company Globus Medical (NYSE:GMED) in Q1 CY2025, with sales falling 1.4% year on year to $598.1 million. On the other hand, the company’s full-year revenue guidance of $2.85 ...

In trading on Friday, shares of Globus Medical Inc (Symbol: GMED) entered into oversold territory, hitting an RSI reading of 23.1, after changing hands as low as $54.75 per share. By comparison ...

AUDUBON, Pa., May 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that its Board of Directors has authorized a share ...

Globus Medical, Inc. (GMED) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings. Skip to content Home page ...